Narrative review / 2017
EFSA derived a group ADI of 30 mg/kg bw per day for glutamic acid and glutamates, noting exposure exceeded this in some groups.
The EFSA ANS Panel re-evaluated the safety of glutamic acid and glutamates (E 620-625) as food additives. No adverse effects were observed in short-term, subchronic, chronic, or reproductive studies, and no genotoxicity concerns were identified. From a neurodevelopmental toxicity study with a NOAEL of 3,200 mg monosodium glutamate/kg bw per day, the Panel established a group acceptable daily intake (ADI) of 30 mg/kg bw per day (as glutamic acid) using an uncertainty factor of 100. Human data were not suitable for deriving guidance values due to lacking dose-response data, and exposure exceeded the proposed ADI as well as doses linked to adverse effects in some population groups.
- Study type
- Scientific opinion / safety re-evaluation
- Who was studied
- Human data evaluated alongside animal studies; specific population groups
- What was measured
- Safety, toxicity, acceptable daily intake (ADI), and human dietary exposure
THE PAPER
Re-evaluation of glutamic acid (E 620), sodium glutamate (E 621), potassium glutamate (E 622), calcium glutamate (E 623), ammonium glutamate (E 624) and magnesium glutamate (E 625) as food additives.
EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), Mortensen A, Aguilar F, Crebelli R, Di Domenico A, Dusemund B, Frutos MJ, Galtier P, Gott D, Gundert-Remy U, Leblanc JC, Lindtner O, Moldeus P, Mosesso P, Parent-Massin D, Oskarsson A, Stankovic I, Waalkens-Berendsen I, Woutersen RA, Wright M, Younes M, Boon P, Chrysafidis D, Gürtler R, Tobback P, Altieri A, Rincon AM, Lambré C. EFSA J, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.